References
  1. Salvatore Minisola, Munro Peacock, Seijii Fukumoto, et al. Tumour-induced osteomalacia. Nature Reviews Disease Primers 2017;volume 3:Article number: 17044.
  2. Bosman A, Palermo A, Vanderhulst J, et al. Tumour-induced osteomalacia: A Systematic Clinical Review of 895 Cases. Calcif Tissue Int 2022;111(4):367–379.
  3. Hidaka N, Koga M, Kimura S, Hoshino Y, et al. Clinical Challenges in Diagnosis, Tumor Localization and Treatment of Tumor-Induced Osteomalacia: Outcome of a Retrospective Surveillance. J Bone Miner Res 2022;37(8):1479–1488.
  4. Folpe AL, Fanburg-Smith JC, Billings SD, et al. Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature. Am J Surg Pathol 2004;28:1–30.
  5. Pelo S, Gasparini G, Garagiola U, et al. Phosphaturic mesenchymal tumor, an unusual localization in head and neck. J Surg Case Rep 2018;22;5.
  6. Arnaoutakis D, Naseri I. Sinonasal Phosphaturic Mesenchymal Tumor: A Rare and Misinterpreted Entity. J Neurol Surg Rep 2015;76(2):e233–238.
  7. Komínek P, Stárek I, Geierová M, Matoušek P, Zeleník K. Phosphaturic mesenchymal tumour of the sinonasal area: case report and review of the literature. Head Neck Oncol 2011;3:16.
  8. Li X, Jiang Y, Huo L, et al. Nonremission and Recurrent Tumor-Induced Osteomalacia: A Retrospective Study. J Bone Miner Res 2020;35(3):469–477.
  9. Kato H, Koga M, Kinoshita Y, et al. Utility of Multimodality Approach Including Systemic FGF23 Venous Sampling in Localizing Phosphaturic Mesenchymal Tumors. J Endocr Soc 2022;7(2):181.
  10. Ito N, Kubota T, Kitanaka S, et al. Clinical performance of a novel chemiluminescent enzyme immunoassay for FGF23. J Bone Miner Metab 2021;39(6):1066–1075.
  11. Kato H, Hidaka N, Koga M, et al. Performance evaluation of the new chemiluminescent intact FGF23 assay relative to the existing assay system. J Bone Miner Metab 2022;40(1):101–108.
  12. Amin MB, Edge SB, Greene FL, et al, editors. AJCC Cancer Staging Manual. 8th edn. Switzerland: Springer, 2017.
  13. Abuhejleh H, Wunder JS, Ferguson PC, et al. Extended intralesional curettage preferred over resection-arthrodesis for giant cell tumour of the distal radius. Eur J Orthop Surg Traumatol 2020 Jan;30(1): 11–17.
  14. Kobayashi K, Nakao K, Kawai K, et al. Tumor-induced osteomalacia originating from the temporal bone: a case report. Head Neck 2011;33(7):1072–1075.
  15. Mori Y, Ogasawara T, Motoi T, et al. Tumor-induced osteomalacia associated with a maxillofacial tumor producing fibroblast growth factor 23: report of a case and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010;109(3):e57–63.
  16. Acharya RP, Won AM, Moon BS, et al. Tumor-induced hypophosphatemic osteomalacia caused by a mesenchymal tumor of the mandible managed by a segmental mandibulectomy and microvascular reconstruction with a free fibula flap. Head Neck 2019;41(6):E93–E98.
  17. Qari H, Hamao-Sakamoto A, Fuselier C, Cheng YS, Kessler H, Wright J. Phosphaturic Mesenchymal Tumor: 2 New Oral Cases and Review of 53 Cases in the Head and Neck. Head Neck Pathol 2016;10(2):192–200.
  18. Pal R, Bhadada SK, Singhare A, et al. Tumor-induced osteomalacia: experience from three tertiary care centers in India. Endocr Connect 2019;8(3):266–276.
  19. Zhu Z, Xia W, Qi F, et al. Clinical characteristics and surgical outcomes of sinonasal lesions associated with tumor-induced osteomalacia. Otolaryngol Head Neck Surg 2021;165(1):223–231.
  20. Shah R, Lila AR, Jadhav RS, et al. Tumor induced osteomalacia in head and neck region: single center experience and systematic review. Endocr Connect 2019;8(10):1330–1353.
  21. Kobayashi H, Makise N, Ito N, et al. Surgical margin for phosphaturic mesenchymal tumors in soft tissues: An analysis of the radiological histopathological correlation. J Orthop Sci 2021;26(5):870–877.
  22. Kobayashi H, Makise N, Ushiku T, et al. Infiltrative nature of tumor-induced osteomalacia lesions in bone: Correlation between radiological and histopathological features. J Orthop Sci 2019;24(5):900–905.
  23. Haffner D, Emma F, Eastwood DM, et al. Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia. Nat Rev Nephrol 2019;15(7):435–455.